These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12744856)

  • 1. Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids.
    Rollman E; Ramqvist T; Zuber B; Tegerstedt K; Kjerrström Zuber A; Klingström J; Eriksson L; Ljungberg K; Hinkula J; Wahren B; Dalianis T
    Vaccine; 2003 Jun; 21(19-20):2263-7. PubMed ID: 12744856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
    Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
    J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of T-cell deficient mice against polyomavirus infection using viral pseudocapsids or temperature sensitive mutants.
    Heidari S; Vlastos A; Ramqvist T; Clark B; Griffin BE; Garcia MI; Perez M; Amati P; Dalianis T
    Vaccine; 2002 Feb; 20(11-12):1571-8. PubMed ID: 11858864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.
    Gedvilaite A; Zvirbliene A; Staniulis J; Sasnauskas K; Krüger DH; Ulrich R
    Viral Immunol; 2004; 17(1):51-68. PubMed ID: 15018662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration.
    Fric J; Marek M; Hrusková V; Holán V; Forstová J
    Vaccine; 2008 Jun; 26(26):3242-51. PubMed ID: 18468739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.
    Fan H; Tong T; Chen H; Guo A
    Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.
    Franzén AV; Tegerstedt K; Holländerova D; Forstová J; Ramqvist T; Dalianis T
    In Vivo; 2005; 19(2):323-6. PubMed ID: 15796193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of monoclonal antibodies specific for major capsid VP1 protein of trichodysplasia spinulosa-associated polyomavirus.
    Khatun H; Yamaoka Y; Matsushima Y; Matsunaga S; Kimura H; Ho J; Shuda M; Ryo A
    Microbiol Immunol; 2018 Dec; 62(12):763-773. PubMed ID: 30537287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids.
    Soeda E; Krauzewicz N; Cox C; Stokrová J; Forstová J; Griffin BE
    Gene Ther; 1998 Oct; 5(10):1410-9. PubMed ID: 9930347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
    Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
    J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus.
    Li YG; Tian FL; Gao FS; Tang XS; Xia C
    Vaccine; 2007 Jan; 25(5):902-11. PubMed ID: 17028078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaffolded Antigens in Yeast Cell Particle Vaccines Provide Protection against Systemic Polyoma Virus Infection.
    Tipper DJ; Szomolanyi-Tsuda E
    J Immunol Res; 2016; 2016():2743292. PubMed ID: 27213160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune effects of four coxsackievirus B3 VP1 DNA fusion vaccines in mice].
    Liu GX; Lan JM; Chuai X; Gao ZY; Jin YH; Zhang YH; Xie LX; Yin CF; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):103-6. PubMed ID: 20230664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA immunization of mice against the VP1 capsid protein of coxsackievirus B4.
    Toniolo A; Falcone V; Bernasconi C; Basolo F; Speziale P; Onodera T
    Scand J Immunol; 2002 Nov; 56(5):448-55. PubMed ID: 12410794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice.
    Suradhat S; Yoo D; Babiuk LA; Griebel P; Baca-Estrada ME
    Viral Immunol; 1997; 10(3):117-27. PubMed ID: 9344334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles.
    Szomolanyi-Tsuda E; Le QP; Garcea RL; Welsh RM
    J Virol; 1998 Aug; 72(8):6665-70. PubMed ID: 9658113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a DNA vaccine against chicken anemia virus by using a bicistronic vector expressing VP1 and VP2 proteins of CAV.
    Moeini H; Omar AR; Rahim RA; Yusoff K
    Comp Immunol Microbiol Infect Dis; 2011 May; 34(3):227-36. PubMed ID: 21146874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus.
    Heidari S; Krauzewicz N; Kalantari M; Vlastos A; Griffin BE; Dalianis T
    J Virol; 2000 Dec; 74(24):11963-5. PubMed ID: 11090197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
    Yin L; Chai D; Yue Y; Dong C; Xiong S
    Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.